4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-031015
President & CEO sold 8,968 shares at $22.51 ($201,870)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2020-05-18 | Sale | −8,968 | $22.51 | $201,870 | 375,903 | D: show line 1 in the form |
| Open-market sales · 8,968 sh · avg $22.51 · $201,870 | |||||||
Loading xslF345X03/doc4.xml…